1. Taglieri N, Bonfiglioli R, Bon I, Malosso P, Corovic A, Bruno M, Le E, Granozzi B, Palmerini T, Ghetti G, Tamburello M, Bruno AG, Saia F, Tarkin JM, Rudd JHF, Calza L, Fanti S, Re MC, Galie N. Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people. J Nucl Cardiol 2021.
2. Stolcova M, Meucci F, Moretti C, Chiriatti N, Marcelli C, Mattesini A, Taglieri N, Ristalli F, Galie N, Palmerini T, Di Mario C, Saia F. Long-term echocardiographic findings after TAVR: 5-year follow-up in 400 consecutive patients. Intern Emerg Med 2021.
3. Orzalkiewicz M, Bruno AG, Taglieri N, Ghetti G, Marrozzini C, Galie N, Palmerini T, Saia F. Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation in a Large and Noncalcified Annulus. JACC Cardiovasc Interv 2021.
4. Montalto C, Crimi G, Morici N, Piatti L, Grosseto D, Sganzerla P, Tortorella G, De Rosa R, De Luca L, De Luca G, Palmerini T, Valgimigli M, Savonitto S, De Servi S. Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores. Int J Cardiol 2021; 328:22-28.
5. Madhavan MV, Bikdeli B, Redfors B, Biondi-Zoccai G, Varunok NJ, Burton JR, Crowley A, Francese DP, Gupta A, C DERN, Chatterjee S, Palmerini T, Benedetto U, You SC, Ohman EM, Kastrati A, Steg PG, Gibson CM, Angiolillo DJ, Krumholz HM, Stone GW. Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials. Minerva Cardiol Angiol 2021; 69(4):398-407.
6. Ghetti G, Taglieri N, Donati F, Minnucci M, Bruno AG, Palmerini T, Saia F, Marrozzini C, Galie N. Correlation between aortic root dimension and coronary ectasia. Coron Artery Dis 2021; 32(4):335-339.
7. Bruno AG, Taglieri N, Saia F, Pini R, Gallitto E, Ghetti G, Orzalkiewicz M, Marrozzini C, Faggioli G, Gargiulo M, Leone A, Savini C, Pacini D, Galie N, Palmerini T. Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach. JACC Cardiovasc Interv 2021; 14(15):e183-e187.
8. Taglieri N, Bruno AG, Ghetti G, Marrozzini C, Saia F, Galie N, Palmerini T. Target Lesion Failure With Current Drug-Eluting Stents: Evidence From a Comprehensive Network Meta-Analysis. JACC Cardiovasc Interv 2020; 13(24):2868-2878.
9. Taglieri N, Bruno AG, Bacchi Reggiani ML, D'Angelo EC, Ghetti G, Bruno M, Palmerini T, Rapezzi C, Galie N, Saia F. Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease. Int J Cardiol 2020; 309:63-69.
10. Saia F, Palmerini T, Marcelli C, Chiarabelli M, Taglieri N, Ghetti G, Negrello F, Moretti C, Bruno AG, Compagnone M, Corsini A, Castelli A, Marrozzini C, Galie N. Routine minimalist transcatheter aortic valve implantation with local anesthesia only. J Cardiovasc Med (Hagerstown) 2020; 21(10):805-811.
11. Saia F, Palmerini T, Compagnone M, Battistini P, Moretti C, Taglieri N, Marcelli C, Bruno AG, Ghetti G, Corsini A, Bacchi Reggiani ML, Marrozzini C, Rapezzi C. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2020; 95(1):19-27.
12. Saia F, Gandolfo C, Palmerini T, Berti S, Doshi SN, Laine M, Marcelli C, Piva T, Ribichini F, De Benedictis M, Cardaioli F, Cannata S, Tarantini G. In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry. EuroIntervention 2020; 15(14):1240-1247.
13. Pelliccia F, Pasceri V, Marazzi G, Cacciotti L, Placanica A, Gragnano F, Niccoli G, Palmerini T, Tanzilli G, Speciale G, Granatelli A, Calabro P, Crea F, Gaudio C. Predictive ability of longitudinal changes in PRECISE-DAPT score in patients on dual antiplatelet therapy: The RE-SCORE multicentre prospective registry. Eur J Prev Cardiol 2020:2047487320937846.
14. Palmerini T, Saia F, Bruno AG, Orzalkiewicz M, Bartorelli AL. Reply: Can We State That Placing a Stent Is Sufficient? JACC Cardiovasc Interv 2020; 13(11):1382-1383.
15. Palmerini T, Chakravarty T, Saia F, Bruno AG, Bacchi-Reggiani ML, Marrozzini C, Patel C, Patel V, Testa L, Bedogni F, Ancona M, Montorfano M, Chieffo A, Olivares P, Bartorelli AL, Buscaglia A, Porto I, Nickenig G, Grube E, Sinning JM, De Carlo M, Petronio AS, Barbanti M, Tamburino C, Iadanza A, Burzotta F, Trani C, Fraccaro C, Tarantini G, Aranzulla TC, De Benedictis M, Pagnotta P, Stefanini GG, Miura M, Taramasso M, Kang JH, Kim HS, Codner P, Kornowski R, Pelliccia F, Vignali L, Taglieri N, Ghetti G, Leone A, Galie N, Makkar R. Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry. JACC Cardiovasc Interv 2020; 13(6):739-747.
16. Palmerini T, Barozzi C, Tomasi L, Riva DD, Marengo M, Cicoria G, Bruno AG, Bacchi-Reggiani ML, Naldi M, Bartolini M, Fanti S, Galie N, Stone GW. In vitro thrombogenicity of drug-eluting and bare metal stents. Thromb Res 2020; 185:43-48.
17. Montalto C, Crimi G, Morici N, Palmerini T, Valgimigli M, Savonitto S, De Servi S. Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults. Thromb Haemost 2020.
18. Madhavan MV, Kirtane AJ, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C, Mehran R, McAndrew T, Serruys PW, Leon MB, Pocock SJ, Stone GW. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol 2020; 75(6):590-604.
19. Madhavan MV, Bikdeli B, Redfors B, Biondi-Zoccai G, Varunok NJ, Burton JR, Crowley A, Francese DP, Gupta A, Der Nigoghossian C, Chatterjee S, Palmerini T, Benedetto U, You SC, Ohman M, Kastrati A, Steg PG, Gibson CM, Angiolillo DJ, Krumholz HM, Stone GW. Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials. Minerva Cardioangiol 2020.
20. Ghetti G, Taglieri N, Donati F, Minnucci M, Bruno AG, Palmerini T, Saia F, Marrozzini C, Galie N. Correlation between aortic root dimension and coronary ectasia. Coron Artery Dis 2020.
21. Compagnone M, Taglieri N, Celeski M, Ghetti G, Marrozzini C, Reggiani MB, Nardi E, Orzalkiewicz M, Bruno AG, Galie N, Saia F, Palmerini T. Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease. Am J Cardiol 2020; 128:94-100.
22. Compagnone M, Marchetti G, Taglieri N, Ghetti G, Bruno AG, Orzalkiewicz M, Marrozzini C, Bacchi Reggiani ML, Palmerini T, Galie N, Saia F. Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement. Int J Cardiol 2020; 318:27-31.
23. Bruno AG, Santona L, Palmerini T, Taglieri N, Marrozzini C, Ghetti G, Orzalkiewicz M, Galie N, Saia F. Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly. Expert Rev Cardiovasc Ther 2020; 18(10):663-680.
24. Baldi E, Compagnone M, Errigo D, Ferlini M, Ziacchi M, Castagno D, Minguzzi A, Demarchi A, Savastano S, Bruno F, Golzio PG, Palmerini T, Saia F, Di Giacomo C, Mauri S, Biffi M, De Ferrari GM, Rordorf R. Long-term percentage of ventricular pacing in patients requiring pacemaker implantation after transcatheter aortic valve replacement: A multicenter 10-year experience. Heart Rhythm 2020; 17(11):1897-1903.
25. Palmerini T, Bruno AG, Gilard M, Morice MC, Valgimigli M, Montalescot G, Collet JP, Della Riva D, Bacchi-Reggiani ML, Steg PG, Diallo A, Vicaut E, Helft G, Nakamura M, Genereux P, Vahl TP, Stone GW. Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation. Circ Cardiovasc Interv 2019; 12(3):e007541.
26. Kang J, Park KW, Palmerini T, Stone GW, Lee MS, Colombo A, Chieffo A, Feres F, Abizaid A, Bhatt DL, Valgimigli M, Hong MK, Jang Y, Gilard M, Morice MC, Park DW, Park SJ, Jeong YH, Park J, Koo BK, Kim HS. Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs. Thromb Haemost 2019; 119(1):149-162.
27. Compagnone M, Moretti C, Marcelli C, Taglieri N, Ghetti G, Corsini A, Bruno M, Bruno AG, Orzalkiewicz M, Marrozzini C, Bacchi Reggiani ML, Palmerini T, Saia F. Surgical Risk Scores Applied to Transcatheter Aortic Valve Implantation: Friends or Foes? Short-Term and Long-Term Outcomes From a Single-Center Registry. J Invasive Cardiol 2019; 31(10):E282-E288.
28. Weymann A, Popov AF, Sabashnikov A, Ali-Hasan-Al-Saegh S, Ryazanov M, Tse G, Mirhosseini SJ, Liu T, Lotfaliani M, Sedaghat M, Baker WL, Ghanei A, Yavuz S, Zeriouh M, Izadpanah P, Dehghan H, Testa L, Nikfard M, Sa M, Mashhour A, Nombela-Franco L, Rezaeisadrabadi M, D'Ascenzo F, Zhigalov K, Benedetto U, Aminolsharieh Najafi S, Szczechowicz M, Roever L, Meng L, Gong M, Deshmukh AJ, Palmerini T, Linde C, Filipiak KJ, Stone GW, Biondi-Zoccai G, Calkins H. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis. Kardiol Pol 2018; 76(2):440-451.
29. Weymann A, Ali-Hasan-Al-Saegh S, Popov AF, Sabashnikov A, Mirhosseini SJ, Liu T, Tse G, Lotfaliani M, Ghanei A, Testa L, D'Ascenzo F, Benedetto U, Dehghan H, Roever L, Sa M, Baker WL, Yavuz S, Zeriouh M, Mashhour A, Nombela-Franco L, Jang JS, Meng L, Gong M, Deshmukh AJ, Palmerini T, Linde C, Filipiak KJ, Biondi-Zoccai G, Calkins H, Stone GW. Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis. Kardiol Pol 2018; 76(1):107-118.
30. Palmerini T, Della Riva D, Biondi-Zoccai G, Leon MB, Serruys PW, Smits PC, von Birgelen C, Ben-Yehuda O, Genereux P, Bruno AG, Jenkins P, Stone GW. Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients. JACC Cardiovasc Interv 2018; 11(9):892-902.
31. Lee SY, Hong MK, Palmerini T, Kim HS, Valgimigli M, Feres F, Colombo A, Gilard M, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Stone GW. Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials. JACC Cardiovasc Interv 2018; 11(5):435-443.
32. Hwang D, Park KW, Lee JM, Rhee TM, Hong MK, Jang Y, Valgimigli M, Colombo A, Gilard M, Palmerini T, Stone GW, Kim HS. Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease. Am Heart J 2018; 197:103-112.
33. Genereux P, Giustino G, Redfors B, Palmerini T, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Mehran R, Kirtane AJ, Stone GW. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. Int J Cardiol 2018; 268:61-67.
34. De Rosa R, Palmerini T, Piscione F. Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing? Int J Cardiol 2018; 271:30.
35. De Rosa R, Palmerini T, De Servi S, Belmonte M, Crimi G, Cornara S, Calabro P, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Genereux P, Angiolillo D, Piscione F, Galasso G. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study. Int J Cardiol 2018; 259:20-25.
36. Crimi G, Somaschini A, Cattaneo M, Angiolillo DJ, Piscione F, Palmerini T, De Servi S. Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromes. Platelets 2018; 29(3):309-311.
37. Cornara S, Crimi G, Somaschini A, Cattaneo M, Angiolillo DJ, Palmerini T, De Servi S. Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes. Platelets 2018; 29(5):528-530.
38. Ukena C, Leonardi S, Palmerini T, Lansky A, Montalescot G, Valgimigli M. Will PIONEER AF-PCI change my practice? EuroIntervention 2017; 13(5):e609-e612.
39. Toso A, De Servi S, Leoncini M, Angiolillo DJ, Calabro P, Piscione F, Cattaneo M, Maffeo D, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Genereux P, Bellandi F, Barozzi C, Tomasi L, Della Riva D, Palmerini T. Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome. J Thromb Thrombolysis 2017; 44(3):355-361.
40. Sawaya FJ, Morice MC, Spaziano M, Mehran R, Didier R, Roy A, Valgimigli M, Kim HS, Woo Park K, Hong MK, Kim BK, Jang Y, Feres F, Abizaid A, Costa RA, Colombo A, Chieffo A, Giustino G, Stone GW, Bhatt DL, Palmerini T, Gilard M. Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials. Catheter Cardiovasc Interv 2017; 89(2):178-189.
41. Redfors B, Palmerini T, Caixeta A, Ayele GM, Francese DP, Mehran R, Brilakis ES, Kirtane AJ, Karmpaliotis D, Stone GW, Genereux P. Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. J Invasive Cardiol 2017; 29(4):123-131.
42. Redfors B, He CH, Palmerini T, Caixeta A, Giustino G, Ayele GM, Kirtane AJ, Mehran R, Stone GW, Genereux P. The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery. J Invasive Cardiol 2017; 29(2):42-49.
43. Podda GM, Grossi E, Palmerini T, Buscema M, Femia EA, Della Riva D, de Servi S, Calabro P, Piscione F, Maffeo D, Toso A, Palmieri C, De Carlo M, Capodanno D, Genereux P, Cattaneo M. Prediction of high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndromes. Int J Cardiol 2017; 240:60-65.
44. Piccolo R, Feres F, Abizaid A, Gilard M, Morice MC, Hong MK, Kim HS, Colombo A, Bhatt DL, Palmerini T, Stone GW, Windecker S, Valgimigli M. Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis. JACC Cardiovasc Interv 2017; 10(16):1621-1630.
45. Palmerini T, Serruys P, Kappetein AP, Genereux P, Riva DD, Reggiani LB, Christiansen EH, Holm NR, Thuesen L, Makikallio T, Morice MC, Ahn JM, Park SJ, Thiele H, Boudriot E, Sabatino M, Romanello M, Biondi-Zoccai G, Cavalcante R, Sabik JF, Stone GW. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Am Heart J 2017; 190:54-63.
46. Palmerini T, Della Riva D, Stone GW. Reply: Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm. J Am Coll Cardiol 2017; 70(10):1305-1306.
47. Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Sangiorgi D, Biondi-Zoccai G, Genereux P, Angelini GD, Pufulete M, White J, Bhatt DL, Stone GW. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. Eur Heart J 2017; 38(14):1034-1043.
48. Palmerini T, Biondi-Zoccai G, Stone GW. Reply: The Optimal Duration of Dual-Antiplatelet Therapy After Coronary Stenting: Shorter or Longer? J Am Coll Cardiol 2017; 70(17):2210-2211.
49. Palmerini T, Biondi Zoccai G. Iteration of second-generation drug-eluting stents: the missing piece of evidence. EuroIntervention 2017; 12(16):1927-1929.
50. Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Ahn JM, Park SJ, Schupke S, Kastrati A, Montalescot G, Steg PG, Diallo A, Vicaut E, Helft G, Biondi-Zoccai G, Xu B, Han Y, Genereux P, Bhatt DL, Stone GW. Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting. J Am Coll Cardiol 2017; 69(16):2011-2022.
51. Palmerini T. Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete? Catheter Cardiovasc Interv 2017; 89(S1):510-511.
52. Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Palmerini T, Stone GW. Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clin Res Cardiol 2017; 106(3):165-173.
53. Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 2017; 389(10073):1025-1034.
54. Biondi-Zoccai G, Marullo AGM, Peruzzi M, Palmerini T, Schirone L, Palmerio S, Giordano A, Frati G. Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies? J Am Coll Cardiol 2017; 69(20):2575-2576.
55. Ballocca F, D'Ascenzo F, Moretti C, Diletti R, Budano C, Palazzuoli A, Reed MJ, Palmerini T, Dudek D, Galassi A, Omede P, Mieghem NM, Ferenbach D, Pavani M, Della Riva D, Mills NL, Van Domburgh RT, Mariani A, Dziewierz A, di Cuia M, Jan van Geuns R, Zijlstra F, Bergerone S, Marra S, Biondi Zoccai G, Gaita F. High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study. Cardiol J 2017; 24(2):139-150.
56. Taglieri N, Bacchi Reggiani ML, Ghetti G, Saia F, Dall'Ara G, Gallo P, Moretti C, Palmerini T, Marrozzini C, Marzocchi A, Rapezzi C. Risk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One 2016; 11(7):e0158769.
57. Palmerini T, Stone GW. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence. Eur Heart J 2016; 37(4):353-364.
58. Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Colombo A, Gilard M, Palmerini T, Stone GW. Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents. Circ Cardiovasc Interv 2016; 9(11).
59. Giustino G, Chieffo A, Palmerini T, Valgimigli M, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Gilard M, Morice MC, Sawaya F, Sardella G, Genereux P, Redfors B, Leon MB, Bhatt DL, Stone GW, Colombo A. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. J Am Coll Cardiol 2016; 68(17):1851-1864.
60. Gargiulo G, Windecker S, da Costa BR, Feres F, Hong MK, Gilard M, Kim HS, Colombo A, Bhatt DL, Kim BK, Morice MC, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016; 355:i5483.
61. De Servi S, Goedicke J, Ferlini M, Palmerini T, Syvanne M, Montalescot G. Prasugrel versus clopidogrel in acute coronary syndromes treated with PCI: Effects on clinical outcome according to culprit artery location. Int J Cardiol 2016; 223:632-638.
62. De Servi S, Crimi G, Calabro P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo DJ, Palmerini T. Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. EuroIntervention 2016; 12(3):312-318.
63. Bettinger N, Palmerini T, Caixeta A, Dressler O, Litherland C, Francese DP, Giustino G, Mehran R, Leon MB, Stone GW, Genereux P. Risk stratification of patients undergoing medical therapy after coronary angiography. Eur Heart J 2016; 37(40):3103-3110.
64. Yadav M, Genereux P, Palmerini T, Caixeta A, Madhavan MV, Xu K, Brener SJ, Mehran R, Stone GW. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter Cardiovasc Interv 2015; 85(1):1-10.
65. Taglieri N, Ghetti G, Saia F, Moretti C, Gallo P, Dall'Ara G, Palmerini T, Marrozzini C, Rapezzi C, Marzocchi A. Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography. J Invasive Cardiol 2015; 27(2):70-77.
66. Palmerini T, Zoccai GB, Benedetto U, Stone GW. Mortality risk with dual antiplatelet therapy? - Authors' reply. Lancet 2015; 386(10003):1535.
67. Palmerini T, Sangiorgi D, Valgimigli M, Biondi-Zoccai G, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Mariani A, Della Riva D, Genereux P, Leon MB, Bhatt DL, Bendetto U, Rapezzi C, Stone GW. Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. J Am Coll Cardiol 2015; 65(11):1092-1102.
68. Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachojannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. J Am Coll Cardiol 2015; 65(23):2496-2507.
69. Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials. Lancet 2015; 385(9985):2371-2382.
70. Madhavan MV, Genereux P, Palmerini T, Caixeta A, Xu K, McAndrew TC, Francese DP, Kirtane AJ, Mehran R, Stone GW. The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial. J Invasive Cardiol 2015; 27(4):203-211.
71. Genereux P, Rutledge DR, Palmerini T, Caixeta A, Kedhi E, Hermiller JB, Wang J, Krucoff MW, Jones-McMeans J, Sudhir K, Simonton CA, Serruys PW, Stone GW. Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials. Circ Cardiovasc Interv 2015; 8(5).
72. Genereux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Yadav M, Francese DP, Palmerini T, Kirtane AJ, Litherland C, Mehran R, Stone GW. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. J Am Coll Cardiol 2015; 66(9):1036-1045.
73. Genereux P, Campos CM, Yadav M, Palmerini T, Caixeta A, Xu K, Francese DP, Dangas GD, Mehran R, Leon MB, Serruys PW, Stone GW. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. EuroIntervention 2015; 11(6):634-642.
74. Genereux P, Campos CM, Farooq V, Bourantas CV, Mohr FW, Colombo A, Morel MA, Feldman TE, Holmes DR, Jr., Mack MJ, Morice MC, Kappetein AP, Palmerini T, Stone GW, Serruys PW. Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention. Am J Cardiol 2015; 116(2):174-186.
75. Genereux P, Bernard S, Palmerini T, Caixeta A, Rosner G, Reiss GR, Xu K, Mehran R, Stone GW. Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial. EuroIntervention 2015; 11(4):399-406.
76. Biondi-Zoccai G, Abbate A, Benedetto U, Palmerini T, D'Ascenzo F, Frati G. Network meta-analysis for evidence synthesis: what is it and why is it posed to dominate cardiovascular decision making? Int J Cardiol 2015; 182:309-314.
77. Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, ten Berg J, Janssen P, Angiolillo DJ, Siller-Matula JM, Marcucci R, Patti G, Mangiacapra F, Valgimigli M, Morel O, Palmerini T, Price MJ, Cuisset T, Kastrati A, Stone GW, Sibbing D. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015; 36(27):1762-1771.
78. Xu B, Genereux P, Yang Y, Leon MB, Xu L, Qiao S, Wu Y, Yan H, Chen J, Zhao Y, Palmerini T, Stone GW, Gao R. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention. JACC Cardiovasc Interv 2014; 7(10):1128-1137.
79. Taglieri N, Saia F, Alessi L, Cinti L, Reggiani ML, Lorenzini M, Marrozzini C, Palmerini T, Ortolani P, Rosmini S, Dall'Ara G, Gallo P, Ghetti G, Branzi A, Marzocchi A, Rapezzi C. Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care 2014; 3(4):326-339.
80. Taglieri N, Bacchi Reggiani ML, Palmerini T, Ghetti G, Saia F, Gallo P, Moretti C, Dall'Ara G, Marrozzini C, Marzocchi A, Rapezzi C. Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention. Am J Cardiol 2014; 113(11):1807-1814.
81. Palmerini T, Savini C, Di Eusanio M. Risks of Stroke After Coronary Artery Bypass Graft - Recent Insights and Perspectives. Interv Cardiol 2014; 9(2):77-83.
82. Palmerini T, Calabro P, Piscione F, De Servi S, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Mariani A, Taglieri N, Reggiani LB, Bianchi R, De Rosa R, Mariani M, Podda G, Genereux P, Stone GW, Angiolillo DJ. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study. JACC Cardiovasc Interv 2014; 7(10):1117-1127.
83. Palmerini T, Biondi-Zoccai G, Stone GW. Stent selection to minimize the risk of stent thrombosis. Curr Opin Cardiol 2014; 29(6):578-585.
84. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, Genereux P, Stone GW. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2014; 63(4):299-307.
85. Madhavan MV, Genereux P, Rubin J, Palmerini T, Caixeta A, Xu K, Weisz G, Mehran R, Stone GW. Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol 2014; 113(8):1331-1337.
86. Kedhi E, Genereux P, Palmerini T, McAndrew TC, Parise H, Mehran R, Dangas GD, Stone GW. Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. J Am Coll Cardiol 2014; 63(20):2111-2118.
87. Genereux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. J Am Coll Cardiol 2014; 63(18):1845-1854.
88. Genereux P, Madhavan MV, Mintz GS, Maehara A, Kirtane AJ, Palmerini T, Tarigopula M, McAndrew T, Lansky AJ, Mehran R, Brener SJ, Stone GW. Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials). Am J Cardiol 2014; 113(6):930-935.
89. D'Ascenzo F, Barbero U, Moretti C, Palmerini T, Della Riva D, Mariani A, Omede P, DiNicolantonio JJ, Biondi-Zoccai G, Gaita F. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials. Contemp Clin Trials 2014; 38(1):51-58.
90. Caixeta A, Genereux P, Palmerini T, Lansky AJ, Mehran R, Dangas GD, Xu K, Brener SJ, Stone GW. Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). Am J Cardiol 2014; 113(2):203-210.
91. Yadav M, Palmerini T, Caixeta A, Madhavan MV, Sanidas E, Kirtane AJ, Stone GW, Genereux P. Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol 2013; 62(14):1219-1230.
92. Taglieri N, Palmerini T, Rapezzi C, Marzocchi A. Prognostic significance of baseline white blood cell count in patients with non-ST-segment elevation acute coronary syndrome. Cardiology 2013; 125(2):90-91.
93. Taglieri N, Dall'Ara G, Rapezzi C, Saia F, Cinti L, Rosmini S, Alessi L, Vagnarelli F, Moretti C, Palmerini T, Marrozzini C, Montefiori M, Branzi A, Marzocchi A. Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. J Cardiovasc Med (Hagerstown) 2013; 14(6):430-437.
94. Taglieri N, Bacchi Reggiani ML, Palmerini T, Cinti L, Saia F, Guastaroba P, Marrozzini C, Moretti C, Montefiori M, Rosmini S, Alessi L, Vagnarelli F, Branzi A, Rapezzi C, Marzocchi A. Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. Cardiology 2013; 124(2):97-104.
95. Saia F, Marrozzini C, Ciuca C, Guastaroba P, Taglieri N, Palmerini T, Bordoni B, Moretti C, Dall'ara G, Branzi A, Marzocchi A. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention 2013; 8(12):1388-1397.
96. Palmerini T, Tomasi L, Barozzi C, Della Riva D, Mariani A, Taglieri N, Leone O, Ceccarelli C, De Servi S, Branzi A, Genereux P, Stone GW, Ahamed J. Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. PLoS One 2013; 8(12):e81501.
97. Palmerini T, Genereux P, Mehran R, Dangas G, Caixeta A, Riva DD, Mariani A, Xu K, Stone GW. Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). Am J Cardiol 2013; 111(9):1237-1245.
98. Palmerini T, Brener SJ, Mehran R, Dangas G, Genereux P, Riva DD, Mariani A, Xu K, Stone GW. Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial. Circ Cardiovasc Interv 2013; 6(5):518-526.
99. Palmerini T, Brener SJ, Genereux P, Maehara A, Della Riva D, Mariani A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Fahy M, Xu K, Gibson CM, Stone GW. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). Am J Cardiol 2013; 112(12):1860-1866.
100. Palmerini T, Biondi-Zoccai G, Riva DD, Mariani A, Savini C, Di Eusanio M, Genereux P, Frati G, Marullo AG, Landoni G, Greco T, Branzi A, De Servi S, Di Credico G, Taglieri N, Williams MR, Stone GW. Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. Am Heart J 2013; 165(6):910-917 e914.
101. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Stone GW. Response to letter by Messeri et al. Am Heart J 2013; 166(3):e19.
102. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabate M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2013; 62(6):496-504.
103. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Genereux P, Branzi A, Stone GW. Stent thrombosis with drug-eluting stents: is the paradigm shifting? J Am Coll Cardiol 2013; 62(21):1915-1921.
104. Farooq V, Vergouwe Y, Genereux P, Bourantas CV, Palmerini T, Caixeta A, Garcia-Garcia HM, Diletti R, Morel MA, McAndrew TC, Kappetein AP, Valgimigli M, Windecker S, Dawkins KD, Steyerberg EW, Serruys PW, Stone GW. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. JACC Cardiovasc Interv 2013; 6(7):737-745.
105. Caixeta A, Lansky AJ, Mehran R, Brener SJ, Claessen B, Genereux P, Palmerini T, Witzenbichler B, Guagliumi G, Brodie BR, Dudek D, Fahy M, Dangas GD, Stone GW. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention 2013; 9(2):220-227.
106. Biondi-Zoccai G, Frati G, D'Ascenzo F, Stone GW, Lotrionte M, Palmerini T. Network meta-analyses and mixed treatment comparisons: are they true scientific endeavors? Int J Cardiol 2013; 168(2):1575-1576.
107. Saia F, Marrozzini C, Ciuca C, Bordoni B, Dall'Ara G, Moretti C, Taglieri N, Palmerini T, Branzi A, Marzocchi A. Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? Catheter Cardiovasc Interv 2012; 79(2):315-321.
108. Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, Sangiorgi D, Bacchi Reggiani L, Kaiser C, Kim HS, De Waha A, Ribichini F, Stone GW. Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. Circ Cardiovasc Interv 2012; 5(3):357-364.
109. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Della Riva D, Fahy M, Xu K, Stone GW. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc Interv 2012; 5(11):1108-1116.
110. Palmerini T, Caixeta A, Genereux P, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial. Am Heart J 2012; 163(3):383-391, 391 e381-385.
111. Palmerini T, Biondi-Zoccai G, Reggiani LB, Sangiorgi D, Alessi L, De Servi S, Branzi A, Stone GW. Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 2012; 60(9):798-805.
112. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379(9824):1393-1402.
113. Palmerini T, Alessi L, Rizzo N, Dangas G. Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology. Catheter Cardiovasc Interv 2012; 79(6):990-999.
114. Palmerini T, Alessi L, Dangas G. Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment. Catheter Cardiovasc Interv 2012; 80(2):199-205.
115. Marzocchi A, Taglieri N, Saia F, Marrozzini C, Rapezzi C, Gallo P, Cortesi P, Guastaroba P, Palmerini T, Moretti C, Di Pasquale G, Sangiorgio P, De Palma R. Incidence, treatment and outcome of acute coronary syndromes: a community-based study in the era of myocardial infarction networks. Int J Cardiol 2012; 157(3):419-422.
116. Martinoni A, De Servi S, Politi A, Palmerini T, Musumeci G, Ettori F, Zanini R, Piccaluga E, Sangiorgi D, Repetto A, D'Urbano M, Castiglioni B, Fabbiocchi F, Onofri M, Lauria G, De Cesare N, Sangiorgi G, Lettieri C, Belli G, Poletti F, Pirelli S, Klugman S. Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: a comparison among different scoring systems and clinical definitions. Int J Cardiol 2012; 157(2):207-211.
117. Lemos PA, Saia F, Mariani J, Jr., Marrozzini C, Filho AE, Kajita LJ, Ciuca C, Taglieri N, Bordoni B, Moretti C, Palmerini T, Dracoulakis MD, Jatene FB, Kalil-Filho R, Marzocchi A. Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation. Int J Cardiol 2012; 157(2):288-289.
118. Genereux P, Palmerini T, Caixeta A, Rosner G, Green P, Dressler O, Xu K, Parise H, Mehran R, Serruys PW, Stone GW. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 2012; 59(24):2165-2174.
119. Taglieri N, Saia F, Rapezzi C, Marrozzini C, Bacchi Reggiani ML, Palmerini T, Ortolani P, Melandri G, Rosmini S, Cinti L, Alessi L, Vagnarelli F, Villani C, Branzi A, Marzocchi A. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. Thromb Haemost 2011; 106(1):132-140.
120. Taglieri N, Saia F, Lanzillotti V, Marrozzini, Faccioli R, Iarussi B, Ortolani P, Palmerini T, Cortesi P, Gordini G, Gallo P, Branzi A, Marzocchi A. Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. Acute Card Care 2011; 13(3):143-147.
121. Taglieri N, Marzocchi A, Saia F, Marrozzini C, Palmerini T, Ortolani P, Cinti L, Rosmini S, Vagnarelli F, Alessi L, Villani C, Scaramuzzino G, Gallelli I, Melandri G, Branzi A, Rapezzi C. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. Am J Cardiol 2011; 108(1):21-28.
122. Palmerini T, Mehran R, Dangas G, Nikolsky E, Witzenbichler B, Guagliumi G, Dudek D, Genereux P, Caixeta A, Rabbani L, Weisz G, Parise H, Fahy M, Xu K, Brodie B, Lansky A, Stone GW. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial. Circulation 2011; 123(24):2829-2837, 2827 p following 2837.
123. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol 2011; 57(24):2389-2397.
124. Palmerini T, Dangas G, Mehran R, Caixeta A, Genereux P, Fahy MP, Xu K, Cristea E, Lansky AJ, Stone GW. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial. Circ Cardiovasc Interv 2011; 4(6):577-584.
125. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Alessi L, Nardini P, Bacchi Reggiani ML, Guastaroba P, De Palma R, Grilli R, Picoco C, Gordini G, Branzi A. Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. EuroIntervention 2011; 7(4):449-457.
126. Martinoni A, De Servi S, Boschetti E, Zanini R, Palmerini T, Politi A, Musumeci G, Belli G, De Paolis M, Ettori F, Piccaluga E, Sangiorgi D, Repetto A, D'Urbano M, Castiglioni B, Fabbiocchi F, Onofri M, De Cesare N, Sangiorgi G, Lettieri C, Poletti F, Pirelli S, Klugmann S. Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. Eur J Cardiovasc Prev Rehabil 2011; 18(3):526-532.
127. Genereux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, Lazar D, Jankovic I, Corral MD, Dressler O, Fahy MP, Parise H, Lansky AJ, Stone GW. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 2011; 4(6):553-561.
128. Genereux P, Mehran R, Palmerini T, Caixeta A, Kirtane AJ, Lansky AJ, Brodie BR, Witzenbichler B, Mockel M, Guagliumi G, Peruga JZ, Dudek D, Fahy MP, Dangas G, Stone GW. Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. EuroIntervention 2011; 7(8):905-916.
129. Caixeta A, Stone GW, Mehran R, Lee EA, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Ohman EM, Palmerini T, Syros G, Kittas C, Fahy M, Hooper WC, Lansky AJ, Dangas GD. Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. J Thromb Thrombolysis 2011; 31(2):154-164.
130. Biondi-Zoccai G, Sheiban I, Moretti C, Palmerini T, Marzocchi A, Capodanno D, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Pede F, Ramondo A, Medda M, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, de Servi S. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clin Res Cardiol 2011; 100(5):403-411.
131. Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, de Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, de Servi S. Sex-related differences in patients undergoing percutaneous unprotected left main stenting. EuroIntervention 2010; 5(7):795-800.
132. Saia F, Marrozzini C, Guastaroba P, Ortolani P, Palmerini T, Pavesi PC, Gordini G, Pancaldi LG, Taglieri N, Palma R, Pasquale G, Branzi A, Marzocchi A. Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. Acute Card Care 2010; 12(2):42-50.
133. Saia F, Marrozzini C, Dall'Ara G, Russo V, Martin-Suarez S, Savini C, Ortolani P, Palmerini T, Taglieri N, Bordoni B, Pilato E, Di Bartolomeo R, Branzi A, Marzocchi A. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? J Cardiovasc Med (Hagerstown) 2010; 11(10):727-732.
134. Rossetti E, Mariani M, Poli A, Palmerini T, Finazzi S, Lotzniker M, Sangiorgi D, De Servi S. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2010; 11(5):359-364.
135. Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Franco N, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Medda M, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Lauria G, De Servi S. Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. Am J Cardiol 2010; 105(2):174-178.
136. Palmerini T, De Servi S, Politi A, Martinoni A, Musumeci G, Ettori F, Piccaluga E, Sangiorgi D, Lauria G, Repetto A, Castiglioni B, Fabbiocchi F, Onofri M, De Cesare N, D'Urbano M, Poletti F, Sangiorgi G, Zanini R, Lettieri C, Belli G, Pirelli S, Klugmann S. Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial infarction treated with primary or facilitated percutaneous coronary intervention. Am J Cardiol 2010; 105(5):605-610.
137. Palmerini T, Barozzi C, Tomasi L, Sangiorgi D, Marzocchi A, De Servi S, Ortolani P, Reggiani LB, Alessi L, Lauria G, Bassi M, Branzi A. A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. Thromb Res 2010; 125(4):309-314.
138. Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. Am J Cardiol 2009; 103(2):187-193.
139. Saia F, Marrozzini C, Ortolani P, Palmerini T, Guastaroba P, Cortesi P, Pavesi PC, Gordini G, Pancaldi LG, Taglieri N, di Pasquale G, Branzi A, Marzocchi A. Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009; 95(5):370-376.
140. Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Ruffini M, Bartorelli AL, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Barlocco F, Lauria G, De Servi S. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J 2009; 30(17):2087-2094.
141. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli AL, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, Lauria G, De Servi S. Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. J Am Coll Cardiol 2009; 53(14):1176-1181.
142. Palmerini T, De Servi S, Branzi A. Prognostic importance of ventricular arrhythmia in patients treated with percutaneous coronary intervention. JAMA 2009; 302(9):943-944; author reply 944-945.
143. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Baldazzi F, Dall'Ara G, Nardini P, Gianstefani S, Guastaroba P, Grilli R, Branzi A. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J 2009; 30(1):33-43.
144. Capodanno D, Di Salvo ME, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S, Tamburino C. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry. Catheter Cardiovasc Interv 2009; 73(3):310-316.
145. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, De Servi S. Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents. Circ Cardiovasc Interv 2008; 1(3):185-192.
146. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. Am J Cardiol 2008; 102(11):1463-1468.
147. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Baldazzi F, Silenzi S, Bacchi-Reggiani ML, Guastaroba P, Grilli R, Branzi A. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. Eur Heart J 2008; 29(10):1241-1249.
148. Palmerini T, Marzocchi A, Marrozzini C, Reggiani LB, Savini C, Marinelli G, Di Bartolomeo R, Branzi A. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg 2007; 31(4):685-690.
149. Palmerini T, Barlocco F, Santarelli A, Bacchi-Reggiani L, Savini C, Baldini E, Alessi L, Ruffini M, Di Credico G, Piovaccari G, Di Bartolomeo R, Marzocchi A, Branzi A, De Servi S. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). Eur Heart J 2007; 28(22):2714-2719.
150. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Aquilina M, Baldazzi F, Silenzi S, Cooke RM, Reggiani ML, Branzi A. Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization. Catheter Cardiovasc Interv 2007; 69(6):790-798.
151. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Baldazzi F, Silenzi S, Taglieri N, Bacchi-Reggiani ML, Gordini G, Guastaroba P, Grilli R, Branzi A. Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2007; 100(5):787-792.
152. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Aquilina M, Baldazzi F, Silenzi S, Taglieri N, Grosseto D, Bacchi-Reggiani ML, Guastaroba P, Grilli R, Branzi A. Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. Am Heart J 2007; 154(2):366-372.
153. Saia F, Schaar J, Regar E, Rodriguez G, De Feyter PJ, Mastik F, Marzocchi A, Marrozzini C, Ortolani P, Palmerini T, Branzi A, van der Steen AF, Serruys PW. Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. J Cardiovasc Med (Hagerstown) 2006; 7(1):21-28.
154. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros Weldeab M, Marinelli G, Di Bartolomeo R, Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006; 98(1):54-59.
155. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Serantoni C, Aquilina M, Silenzi S, Baldazzi F, Grosseto D, Taglieri N, Cooke RM, Bacchi-Reggiani ML, Branzi A. Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. Eur Heart J 2006; 27(13):1550-1557.
156. Saia F, Marzocchi A, Marrozzini C, Ortolani P, Palmerini T, Sbarzaglia P, Branzi A. Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock. Ital Heart J 2005; 6(5):420-423.
157. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Bacchi-Reggiani L, Virzi S, Gianstefani S, Branzi A. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation 2005; 112(15):2332-2338.
158. Ortolani P, Marzocchi A, Aquilina M, Gaiba W, Neri S, Marrozzini C, Palmerini T, Taglieri N, Branzi A. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis. J Interv Cardiol 2005; 18(3):205-211.
159. Palmerini T, Coller BS, Cervi V, Tomasi L, Marzocchi A, Marrozzini C, Leone O, Piccioli M, Branzi A. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol 2004; 44(8):1570-1577.
160. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Aquilina M, Corliano L, Saia F, Taglieri N, Sbarzaglia P, Bacchi Reggiani ML, Branzi A. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. Ital Heart J 2004; 5(3):189-196.
161. Ortolani P, Marzocchi A, Aquilina M, Gaiba W, Neri S, Bunkheila F, Lombardo E, Pini S, Marrozzini C, Palmerini T, Taglieri N, Sbarzaglia P, Reggiani ML, Barbieri E, Branzi A. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. Catheter Cardiovasc Interv 2004; 63(4):433-438.
162. Ortolani P, Marzocchi A, Gaiba W, Neri S, Marrozzini C, Palmerini T, Aquilina M, Corliano L, Lombardo E, Bunkheila F, Pini S, Sbarzaglia P, Taglieri N, Barbieri E, Branzi A. [Intracoronary beta-radiotherapy in high-risk in-stent restenosis. Prospective results of a single center registry]. Ital Heart J Suppl 2003; 4(8):672-681.
163. Ortolani P, Marzocchi A, Gaiba W, Neri S, Marrozzini C, Palmerini T, Aquilina M, Branzi A. Beta brachytherapy of an old degenerated saphenous vein graft with occlusive in-stent restenosis. Ital Heart J 2003; 4(9):646-650.
164. Palmerini T, Nedelman MA, Scudder LE, Nakada MT, Jordan RE, Smyth S, Gordon RE, Fallon JT, Coller BS. Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates. J Am Coll Cardiol 2002; 40(2):360-366.
165. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Aquilina M, Corliano L, Camplese G, Sbarzaglia P, Branzi A. Ultrasound-assisted stent implantation in small size coronary arteries: a pilot study. Ital Heart J 2001; 2(5):372-378.
166. Marzocchi A, Ortolani P, Piovaccari G, Marrozzini C, Palmerini T, Marinucci L, Saia F, Bacchi-Reggiani ML, Branzi A, Magnani B. Long-term follow-up of stent implantation versus stent-like angioplasty in unstable angina. Cardiologia 1999; 44(3):261-268.
167. Marzocchi A, Ortolani P, Piovaccari G, Marrozzini C, Nobile G, Palmerini T, Marinucci L, Saia F, Bacchi Reggiani ML, Branzi A, Magnani B. Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome. Coron Artery Dis 1999; 10(2):81-88.
168. Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Palmerini T, Branzi A, Magnani B. Antithrombotic therapy after coronary stent placement. Cardiologia 1998; 43(7):717-723.
169. Palmerini T, Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Di Marco M, Di Luzio S, Branzi A, Magnani B. [Implanting of coronary stents in patients with unstable angina]. Cardiologia 1997; 42(4):415-420.
170. Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Palmerini T, Branzi A, Magnani B. Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol 1997; 79(10):1314-1318.
171. Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Palmerini T, Branzi A, Magnani B. Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn 1997; 41(4):371-376.
172. Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Palmerini T, Bacchi ML, Nobile G, Marinucci L, Branzi A, Magnani B. [Endocoronary stent: its use to improve suboptimal outcome of angioplasty]. G Ital Cardiol 1997; 27(12):1271-1276.
173. Piovaccari G, Marzocchi A, Marrozzini C, Ortolani P, Palmerini T, Di Marco M, Di Luzio S, Ferlito M, Branzi A, Magnani B. [Percutaneous aortic valvuloplasty in the adult. When and why is now useful?]. Ann Ital Med Int 1996; 11(4):258-262.
174. Marzocchi A, Piovaccari G, Marrozzini C, Ortolani P, Melandri G, Palmerini T, Nobile G, Branzi A, Magnani B. Intravascular Stenting in a Female Patient with Spontaneous Coronary Dissection and Von WillebrandOs Disease. J Invasive Cardiol 1996; 8(6):257-262.
175. Marzocchi A, Piovaccari G, Marrozzini C, Fattori R, Ortolani P, Castriota F, Cere E, Palmerini T, Branzi A, Magnani B. [Angioplasty in patients already treated with aortocoronary bypass: immediate and short-term results]. Cardiologia 1994; 39(12 Suppl 1):451-456.
176. D'Erasmo E, Acca M, Celi FS, Medici F, Palmerini T, Pisani D. Plasma fibrinogen and platelet count in stroke. J Med 1993; 24(2-3):185-191.
